Axon Enterprise (NASDAQ:AXON) Given New $682.00 Price Target at Barclays

Axon Enterprise (NASDAQ:AXON) had its price objective cut by Barclays from $702.00 to $682.00 in a research note published on Wednesday,Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock.

Several other equities analysts have also recently weighed in on AXON. William Blair reaffirmed an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 3rd. The Goldman Sachs Group reduced their target price on shares of Axon Enterprise from $940.00 to $800.00 and set a “buy” rating for the company in a report on Wednesday, November 5th. Craig Hallum reaffirmed a “buy” rating and issued a $820.00 target price on shares of Axon Enterprise in a research report on Wednesday. Piper Sandler cut their price target on shares of Axon Enterprise from $753.00 to $690.00 and set an “overweight” rating on the stock in a research report on Wednesday. Finally, Royal Bank Of Canada reduced their price objective on shares of Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating for the company in a research note on Wednesday. Sixteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $762.93.

Axon Enterprise Price Performance

AXON stock opened at $520.18 on Wednesday. The stock has a 50-day moving average price of $539.22 and a two-hundred day moving average price of $628.00. Axon Enterprise has a 1 year low of $396.41 and a 1 year high of $885.91. The stock has a market cap of $41.05 billion, a PE ratio of 342.23, a price-to-earnings-growth ratio of 13.33 and a beta of 1.48. The company has a current ratio of 3.12, a quick ratio of 2.89 and a debt-to-equity ratio of 0.57.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 EPS for the quarter, beating analysts’ consensus estimates of $1.60 by $0.55. The company had revenue of $796.72 million for the quarter, compared to analyst estimates of $755.29 million. Axon Enterprise had a return on equity of 2.94% and a net margin of 4.48%.The company’s quarterly revenue was up 38.5% compared to the same quarter last year. During the same period in the previous year, the company posted $2.08 earnings per share. Equities analysts forecast that Axon Enterprise will post 5.8 EPS for the current fiscal year.

Insider Activity at Axon Enterprise

In other news, CFO Brittany Bagley sold 2,000 shares of the company’s stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $580.00, for a total value of $1,160,000.00. Following the sale, the chief financial officer directly owned 103,501 shares of the company’s stock, valued at approximately $60,030,580. This represents a 1.90% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Jennifer H. Mak sold 1,134 shares of Axon Enterprise stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $600.00, for a total value of $680,400.00. Following the transaction, the chief accounting officer owned 13,740 shares of the company’s stock, valued at $8,244,000. The trade was a 7.62% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 48,040 shares of company stock worth $27,249,338 over the last ninety days. Company insiders own 4.40% of the company’s stock.

Institutional Investors Weigh In On Axon Enterprise

A number of large investors have recently added to or reduced their stakes in the business. Creative Financial Designs Inc. ADV acquired a new position in shares of Axon Enterprise in the fourth quarter valued at $28,000. Stone House Investment Management LLC bought a new stake in shares of Axon Enterprise during the 3rd quarter worth about $29,000. New Millennium Group LLC acquired a new position in Axon Enterprise in the 3rd quarter valued at about $29,000. Sound Income Strategies LLC grew its stake in Axon Enterprise by 550.0% in the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after buying an additional 44 shares during the last quarter. Finally, Camelot Portfolios LLC bought a new position in Axon Enterprise in the 4th quarter valued at about $30,000. Institutional investors own 79.08% of the company’s stock.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q4 beat and raised medium/long-term targets — Axon reported $796.7–797M in Q4 revenue (≈+39% YoY) and $2.15 adjusted EPS, beat consensus, issued 2026 revenue guidance well above street estimates and introduced $6B 2028 revenue/strong margin targets. This is the headline catalyst for the rally. Axon reports Q4 2025 revenue of $797 million
• Positive Sentiment: AI is driving bookings and product demand — Management emphasized AI features across cameras, license-plate readers and evidence management that are accelerating deployments and bookings, helping convert device customers into higher‑margin software subscribers. Taser Maker Axon Says Its Business Is Being ‘Supercharged by AI.’
• Positive Sentiment: Government spending and enterprise demand tailwinds — Reports cite strong device and software demand from federal and public‑safety customers (including DHS initiatives) that support the company’s growth runway. Axon shares rise as Taser-maker’s profit gets boost from government spending
• Positive Sentiment: Some sell‑side firms maintain buy ratings — Several analysts reiterated bullish views or maintained Buy ratings based on the AI-driven platform and long-term targets, supporting the upside narrative. Axon: AI-Driven Platform Strength and Long-Term Growth Targets Support Buy Rating
• Neutral Sentiment: Earnings call and presentation available — Full Q4 earnings call transcript and slides were posted; useful for digging into bookings, margin cadence and product adoption metrics. Axon Enterprise, Inc. (AXON) Q4 2025 Earnings Call Transcript
• Neutral Sentiment: Short‑interest data reported but inconclusive — A February short‑interest entry shows zero/NaN values and a 0.0 days ratio, which appears to be a data anomaly and shouldn’t be treated as meaningful without confirmation from exchange filings.
• Negative Sentiment: Analysts trimmed price targets despite the beat — Several firms cut targets after the print (UBS, Barclays, Morgan Stanley, Piper Sandler noted cuts in coverage summaries), which can moderate upside expectations even though many kept overweight/buy ratings. These Analysts Cut Their Forecasts On Axon After Q4 Results

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.